What is the latest research on Ewings sarcoma?
Children’s Hospital and Dana-Farber Cancer Institute are conducting numerous research studies that will help clinicians better understand and treat Ewing’s sarcoma. One current national study in which Children’s Hospital and Dana-Farber are participating involves dose compression, a way of giving more chemotherapy in hopes of improving outcomes for Ewing’s sarcoma patients. With the help of hematopoietic growth factors (proteins that stimulate marrow cells to grow and produce blood cells), patients can receive chemotherapy every two weeks instead of every three weeks, increasing the amount of therapy over a given time period. In the area of stem cell transplantation, the Dana-Farber/Children’s Transplant Program is one of only eight institutions around the country that is investigating the use of umbilical cord transplantation. Also under study is a novel method for preventing graft versus host disease, a serious complication that occurs when transplanted cells do not recognize the tis
